DuLac Farmaceutici Expands U.S. Presence with OneLavi Launch and ECRM Participation

Italian pharmaceutical company DuLac Farmaceutici is making a significant push into the U.S. market, announcing that its products are now available through OneLavi.com as it prepares to participate in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, scheduled for September 14-17 in Palm Beach Gardens, Florida. This dual move underscores the company's commitment to broadening its U.S. footprint beyond its established Amazon presence.

DuLac has already demonstrated strong consumer demand on Amazon, where its Arnica Gel 98% has earned more than 13,000 customer reviews with an average 4.5-star rating, and the Dinaven line has received over 4,000 reviews with a 4.6-star average. These results show that American consumers are responding positively to the brand's Italian-developed products, providing a solid foundation for further expansion.

The addition of OneLavi as a new e-commerce channel represents a strategic step in diversifying distribution. By making its Made in Italy portfolio available to OneLavi customers, DuLac gains another platform to introduce its products to a wider U.S. audience. This move aligns with the company's objective to build a multi-channel presence across e-commerce and traditional retail.

Participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session adds a crucial business-to-business dimension to DuLac's U.S. strategy. During the event, the company will engage in scheduled meetings with buyers representing major health, specialty, food, drug, and mass retail channels. These interactions provide an opportunity to showcase its product portfolio, pharmaceutical heritage, and advanced manufacturing capabilities to potential retail partners. The company aims to establish relationships that can support a larger and more diversified U.S. retail presence as it executes its national expansion strategy.

DuLac brings over 30 years of pharmaceutical industry expertise and pharmacy-channel experience in Italy to this endeavor. Its product development and manufacturing capabilities include the proprietary Arnica Montana Arricchita™ project, indoor vertical farming, micronized Diosmin MPFF technology, solvent-free Supercritical CO₂ Extraction, and manufacturing under internationally recognized GMP and ISO quality frameworks. These factors set DuLac apart in the wellness market, offering consumers products developed with rigorous quality standards.

The combination of established Amazon demand, the new OneLavi channel, and scheduled meetings with major retail buyers positions DuLac for a broader national presence. The company's goal is to build a diversified U.S. presence across e-commerce, retail, wholesale, and other distribution channels, introducing more American consumers to its Italian-developed product portfolio. As DuLac moves from initial market development to a comprehensive national strategy, its participation at ECRM is a pivotal step in forging the partnerships needed to achieve long-term growth in the U.S. market.